Related Experiment Video
Updated: Jul 22, 2026

Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
Frequency, characteristics, and clinical determinants of 'prodrome' in familial Mediterranean fever patients
H Babaoglu1, N Atas1, O Varan1
1Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Gazi University, Ankara, Turkey.
Abstract:
Objective: Prodrome is defined by manifestations that precede a familial Mediterranean fever (FMF) attack and predict its emergence. We aimed to determine the frequency, characteristics, and clinical determinants of prodrome in patients with FMF.Method: This cross-sectional study was conducted in a tertiary rheumatology clinic. During the clinical interview, all patients completed a standardized questionnaire about the pre-attack period. Prodrome was defined as the presence of any recurrent pre-attack manifestation occurring at least 4 h before an attack. Patients were classified according to whether they had prodrome of any kind of attack.Results: The study enrolled 401 patients aged 37.7 ± 11.0 years (mean ± sd). Male gender, M694V/M694V, homozygous MEFV mutation, peritonitis, pleuritis, and arthritis were more frequent in prodrome-positive patients. Altogether, 141 patients (35.2%) had prodrome. Male gender and ever having attack types of peritonitis or arthritis were independent clinical determinants of prodrome [relative risk (95% confidence interval): 1.72 (1.07-2.76), p = 0.02; 4.27 (1.80-10.1), p = 0.001; 1.77 (1.04-3.04), p = 0.04, respectively]. Age, MEFV mutations, pleuritis, and erysipelas-like erythema were not clinical determinants.Conclusions: All FMF patients, particularly males and patients who had peritonitis or arthritis at any time, should be questioned about prodrome. Prodrome should be analysed in terms of elucidating the pathogenesis of FMF and as an opportunity for a secondary prevention strategy for impending attacks. This study may shed light on prodrome for future cytokine or drug studies with the purpose of developing new cost-effective treatment protocols irrespective of colchicine resistance.
Insights
Prodrome, warning signs before a Familial Mediterranean Fever (FMF) attack, occurs in 35.2% of patients. Male gender and a history of peritonitis or arthritis are key predictors of FMF prodrome.
Area of Science:
- Rheumatology
- Genetics
- Internal Medicine
Background:
- Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder characterized by recurrent attacks of fever and inflammation.
- Prodrome, defined as manifestations preceding an FMF attack, is recognized but its frequency and determinants require further elucidation.
- Understanding prodrome is crucial for predicting attacks and potentially developing secondary prevention strategies.
Purpose of the Study:
- To determine the frequency and characteristics of prodrome in patients with Familial Mediterranean Fever (FMF).
- To identify clinical determinants associated with the presence of prodrome in FMF patients.
- To explore the implications of prodrome for understanding FMF pathogenesis and treatment.
Main Methods:
- A cross-sectional study involving 401 FMF patients in a tertiary rheumatology clinic.
- Standardized questionnaires were administered to collect data on pre-attack manifestations (prodrome).
- Prodrome was defined as recurrent pre-attack symptoms occurring at least 4 hours before an FMF attack.
Main Results:
- Prodrome was reported by 141 patients (35.2%).
- Prodrome-positive patients were more likely to be male and have homozygous MEFV mutations (M694V/M694V), peritonitis, pleuritis, or arthritis.
- Independent clinical determinants of prodrome included male gender and a history of peritonitis or arthritis.
Conclusions:
- Clinicians should actively inquire about prodromal symptoms in all FMF patients, especially males and those with a history of peritonitis or arthritis.
- Prodrome offers valuable insights into FMF pathogenesis and presents an opportunity for secondary prevention strategies.
- Further research into FMF prodrome may facilitate the development of novel, cost-effective treatments beyond colchicine resistance.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
Related Concept Videos
Patterns of Fever
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rocky Mountain Spotted Fever
Inflammatory Bowel Disease IV: Clinical Manifestations